| Line Item | 2024-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $0 | — | -100.0% |
| SG&A Expense | $10K | +384.7% | -85.2% |
| Operating Income | -$10K | +24.9% | +87.5% |
| Pre-tax Income | -$10K | +24.9% | +87.5% |
| Net Income | -$10K | +24.9% | +87.5% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2024-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9K | +83.1% | -63.1% |
| Current Assets | $9K | +76.6% | -63.1% |
| Total Assets | $9K | +76.6% | -79.2% |
| Current Liabilities | $50K | +37.2% | -93.5% |
| Total Liabilities | $50K | +37.2% | -93.5% |
| Stockholders' Equity | -$41K | -30.9% |
| Line Item | 2024-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$37K | — | — |
| Financing Cash Flow | $45K | — | — |
| +94.3% |